Table of Contents
- Overview
- Results
- Risks
- Prevention
Glucose-6-phosphate dehydrogenase (G6PD) is a type of protein, called an
Alternative Names
RBC G6PD test; G6PD screen
How the test is performed
Blood is typically drawn from a vein, usually from the inside of the elbow or the back of the hand. The site is cleaned with germ-killing medicine (antiseptic). The health care provider wraps an elastic band around the upper arm to apply pressure to the area and make the vein swell with blood.
Next, the health care provider gently inserts a needle into the vein. The blood collects into an airtight vial or tube attached to the needle. The elastic band is removed from your arm. Once the blood has been collected, the needle is removed, and the puncture site is covered to stop any bleeding.
In infants or young children, a sharp tool called a lancet may be used to puncture the skin and make it bleed. The blood collects into a small glass tube called a pipette, or onto a slide or test strip. A bandage may be placed over the area if there is any bleeding.
How to prepare for the test
No special preparation is usually necessary.
How the test will feel
When the needle is inserted to draw blood, some people feel moderate pain. Others feel only a prick or stinging sensation. Afterward, there may be some throbbing.
Why the test is performed
Your doctor may order this test if you have signs of
Too little G6PD activity leads to the destruction of red blood cells. This process is called
Hemolytic episodes can be triggered by infections, severe stress, certain foods (such as fava beans), and certain drugs, including:
- Antipyretics (drugs used to reduce fever)
- Nitrofurantoin
- Phenacetin
- Primaquine
- Sulfonamides
- Thiazide diuretics
- Tolbutamide
- Quinidine
If this test is done during a hemolytic episode it may be falsely positive and misleading. This is because the cells most likely to have low G6PD levels (older cells) have been destroyed, and those remaining may show normal G6PD levels.
After recovery from the episode, older cells will show lower levels of G6PD, resulting in a positive test.
Review Date: 03/21/2010
Reviewed By: Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of
Physician Assistant Studies, University of Washington, School of
Medicine; James R. Mason, MD, Oncologist, Director, Blood and
Marrow Transplantation Program and Stem Cell Processing Lab,
Scripps Clinic, Torrey Pines, California. Also reviewed by David
Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
